Longitudinal studies of inter-alpha inhibitor proteins in severely septic patients: A potential clinical marker and mediator of severe sepsis

Critical Care Medicine

Volumn 35, Issue 2, 2007, Pages 387-392

  Opal, Steven M ^a   Lim, Yow Pin ^b   Siryaporn, Edward ^b   Moldawer, Lyle L ^c   Pribble, John P ^d   Palardy, John E ^a   Souza, Sonia ^d  

^a BROWN UNIVERSITY   (United States)

^b ProThera Biologics   (United States)

^c UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^d ELI LILLY AND COMPANY   (United States)

Author keywords

Inter alpha inhibitor proteins; Interleukin 6; Pre alpha inhibitor; Protease inhibitors; Severe sepsis

Indexed keywords

1 ALKYL 2 ACETYLGLYCEROPHOSPHOCHOLINE ESTERASE; INTER ALPHA TRYPSIN INHIBITOR; INTERLEUKIN 6; MARKER; RECOMBINANT ENZYME; RECOMBINANT PLATELET ACTIVATING FACTOR ACETYLHYDROLASE; UNCLASSIFIED DRUG;

ADULT; ADULT RESPIRATORY DISTRESS SYNDROME; AGE DISTRIBUTION; ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE SEVERITY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIPLE ORGAN FAILURE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; SEPSIS; SEX DIFFERENCE; STATISTICAL SIGNIFICANCE; TREATMENT DURATION; TREATMENT OUTCOME;

ADULT; ALPHA-GLOBULINS; BIOLOGICAL MARKERS; FEMALE; HUMANS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; SEPSIS; SEVERITY OF ILLNESS INDEX; TIME FACTORS;

EID: 33846439768     PISSN: 00903493     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.CCM.0000253810.08230.83     Document Type: Article

References (37)

1. Caliezi C, Willemin WA, Zeerleder S, et al: C1-esterase inhibitor: An anti-inflammatory agent and its potential use in the treatment of diseases other than hereditary angioedema. Pharamacol Rev 2000; 52:91-112
2. Weiss SJ: Tissue destruction by neutrophils. N Engl J Med 1989; 320:652-676
3. Neijens JH, Abbink JJ, Wachtfogel YT, et al: Plasma elastase alpha 1-antitrypsin and lactoferrin in sepsis: Evidence for neutrophils as mediators in fatal sepsis. J Lab Clin Med 1992; 119:159-168
4. Hirose J, Ozawa T, Miura T, et al: Human neutrophil elastase degrades inter-alpha-inhibitor trypsin inhibitor to liberate urinary trypsin inhibitor related proteins. Biol Pharm Bull 1998; 21:651-661
5. Opal SM, Esmon C: Functional relationships between coagulation and the innate immune response and their respective roles in the pathogenesis of sepsis. Crit Care 2003; 7:23-38
6. Lim Y-P, Bendelja K, Opal S, et al: Correlation between mortality and the levels of inter-alpha inhibitors in the plasma of patients with severe sepsis. J Infect Dis 2003; 188: 919-926
7. Yang S, Lim Y-P, Zhou M, et al: Administration of human inter-alpha-inhibitor maintains hemodynamic stability and improves survival during sepsis. Crit Care Med 2002; 30:617-622
8. Bost F, Diarra-Mehrpour M, Martin J: Inter-alpha-trypsin inhibitor proteoglycan family: A group of proteins binding and stabilizing the extracellular matrix. Eur J Biochem 1998; 252:339-346
9. Fries E, Blom A: Bikunin-Not just a plasma proteinase inhibitor. Int J Biochem Cell 2000; 32:125-137
10. Salier J, Rouet P, Raguenez G, et al: The inter-alpha-inhibitor family: From structure to regulation. Biochem J 1996; 315:1-9
11. Enghild JJ, Thogersen IB, Pizzo SV, et al: Analysis of inter-alpha-trypsin inhibitor-A novel trypsin inhibitor, pre-alpha-trypsin inhibitor, from human plasma: Polypeptide chain stoichiometry an assembly by glycan. J Biol Chem 1989; 264:15975-15981
12. Jenssen TE, Faarvang KL, Ploug M: Carbohydrate as covalent crosslink in human inter-alpha-trypsin inhibitor: A novel plasma protein structure. FEBS Lett 1988; 230: 195-200
13. Mizon C, Queyrel V, Bulduyck M, et al: Human pre-alpha-inhibitor is a positive acutephase protein that is more susceptible than inter-alpha-inhibitor through proteolysis by stimulated neutrophils. Eur J Clin Invest 2000; 30:79-86
14. Baek YW, Brokat S, Padbury JF, et al: Interalpha inhibitor proteins in infants and decreased levels in neonatal sepsis. J Pediatr 2003; 143:11-15
15. Balduyck M, Albani D, Jourdain M, et al: Inflammation-induced systemic proteolysis of inter-alpha-inhibitor in plasma from patients with sepsis. J Lab Clin Med 2000; 135: 188-198
16. Gast A, Bieth JG: Inhibition of human neutrophil elastase by acid-soluble, inter-alphatrypsin inhibitor. Adv Exp Med Biol 1988; 240:75-82
17. Mizon C, Piva F, Queyrel V, et al: Urinary bikunin determination provides insight into protease/protease inhibitor imbalance in patients with inflammatory diseases. Clin Chem Lab Med 2002; 40:579-586
18. Opal SM, Artenstein A, Cristofaro PA, et al: Inter-alpha Inhibitor proteins are endogenous furin inhibitors and are protective in experimental anthrax intoxication. Infect Immun 2005; 73:5101-5105
19. Opal SM, Laterre P-F, Abraham E, et al: Recombinant human platelet-activating factor acetylhydrolase for the treatment of severe sepsis: Results of a Phase III, multicenter, randomized, double-blind, placebo-controlled, clinical trial. Crit Care Med 2004; 32:332-341
20. Mizon C, Bulduyck M, Albani D, et al: Development of an enzyme-linked immunosorbent assay for human plasma inter-alpha inhibitor trypsin inhibitor (ITI) using specific antibodies against each of the H1 and H2 heavy chains. J Immunol Methods 1996; 90: 61-70
21. Girard T, Opal SM, Ely EW: Insights into severe sepsis in older patients: From epidemiology to evidence-based medicine. Clin Infect Dis 2005; 40:719-727
22. Martin GS, Mannino DM, Eaton S, et al: Epidemiology of sepsis in the United States from 1979-2000. N Engl J Med 2003; 348: 1546-1557
23. Wichman MW, Inthorn D, Andress JH, et al: Incidence and mortality of severe sepsis in surgical intensive care patients: The influence of patient gender on disease process and outcome. Intensive Care Med 2000; 26: 167-172
24. Schroder J, Kahlke V, Stauback KH, et al: Gender differences in human sepsis. Arch Surg 1998; 133:1200-1205
25. Diodato MD, Knoferl MW, Schwacha MG, et al: Gender differences in the inflammatory response and survival following haemorrhage and subsequent sepsis. Cytokine 2001; 14:162-169
26. Chadwick CC, Chippari S, Matelan E, et al: Identification of pathway-selective estrogen receptor ligands that inhibit NF B transcriptional activity. Proc Natl Acad Sci 2005; 102: 2543-2548
27. Bindl L, Buderus S, Kahlem P, et al: Genderbased differences in children with sepsis and ARDS: The ESPNIC ARDS Database Group. Intensive Care Med 2003; 29:1770-1773
28. O'Keefe GE, Hunt JL, Purdue GF: An evaluation of risk factors for mortality after burn trauma and the identification of genderdependent differences in outcomes. J Am Coll Surg 2001; 192:153-160
29. Xing Z, Gauldie J, Cox G, et al: IL-6 is an anti-inflammatory cytokine required for controlling local or systemic acute inflammatory responses. J Clin Invest 1998; 101:311-320
30. Jourdain M, Carrett O, Tournoys A, et al: Effects of inter-alpha- inhibitor in experimental endotoxic shock and disseminated intravascular coagulation. Am J Respir Crit Care Med 1997; 156:1825-1833
31. Wisniewski H, Hua J, Poppers D, et al: 1996. TNF/IL-1-inducible protein TSG-6 potentiates plasmin inhibition by inter-alphainhibitor and exerts a strong anti-inflammatory effect in vivo. J Immunol 1996; 156: 1609-1615
32. Gordon V, Klimpel K, Arora N, et al: Proteolytic activation of bacterial toxins by eukaryotic cells is performed by furin and by additional cellular proteases. Infect Immum 1995; 63:82-87
33. Pratt CW, Swaim MW, Pizzo SV: Inflammatory cells degrade inter-alpha inhibitor and liberate urinary protease inhibitors. J Leukoc Biol 1989; 45:1-9
34. Zhu J, Nathan C, Jin Wenwen, et al: Conversion of proepithelin to epithelins: Roles of SLPI and elastase in host defense and wound repair. Cell Press 2002; 111:867-878
35. Nakamura A, Mori Y, Hagiwara K, et al: Increased susceptibility to LPS-induced endotoxin shock in secretory leukoprotease inhibitor (SLPI)-deficient mice. J Exp Med 2003; 197:669-674
36. Wakahara K, Kobayashi H, Yagyu T, et al: Bikunin suppresses lipopolysaccharideinduced lethality through down-regulation of tumor necrosis factor-α and interleukin-1β in macrophages. J Infect Dis 2005; 191:930-938
37. Liony C, Sesbue R, Manchon ND, et al: Inter-alpha-trypsin inhibitor as derivatives in inflammatory syndromes (authors' translation). Presse Med 1991; 20:203-206